Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant factor » significant factors (Expand Search)
factor decrease » factors increases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant factor » significant factors (Expand Search)
factor decrease » factors increases (Expand Search)
-
2221
-
2222
-
2223
-
2224
-
2225
-
2226
-
2227
-
2228
-
2229
-
2230
-
2231
Changes in the neutrophil count.
Published 2025“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
-
2232
Changes in the platelet count.
Published 2025“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
-
2233
Changes in the white blood cell count.
Published 2025“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
-
2234
Changes in the hemoglobin.
Published 2025“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
-
2235
WBC and ANC on day 7 post-chemotherapy.
Published 2025“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
-
2236
General clinical data of 88 patients with NPC.
Published 2025“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
-
2237
CONSORT participant flow diagram.
Published 2025“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
-
2238
S4 File -
Published 2025“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”
-
2239
-
2240